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Abstract
Relapsing polychondritis (RP) is a human autoimmune disease
of unknown etiology in which cartilaginous sites are destroyed
by cyclic inflammatory episodes beginning, most commonly,
during the fourth or fifth decade of life. We have previously
described collagen-induced polychondritis that closely mirrors
RP occurring in young (6–8 weeks old) HLA-DQ6αβ8αβ
transgenic Aβ0 mice, following immunization with heterologous
type II collagen (CII).
We present evidence here that transgenic strains expressing
the DQ6α8β transgene develop spontaneous polychondritis
(SP) at the mouse equivalent of human middle age (4.5–6
months and 40–50 years old, respectively) and display
polyarthritis, auricular chondritis and nasal chondritis – three of
the most common sites affected in RP. Auricular chondritis in
SP, like RP but unlike CII-induced polychondritis, exhibited a
relapsing/remitting phenotype, requiring several inflammatory
cycles before the cartilage is destroyed. Elevated serum levels
of total IgG corresponded with the onset of disease in SP, as in
RP and CII-induced polychondritis. No CII-specific immune
response was detected in SP, however – more closely mirroring
RP, in which as few as 30% of RP patients have been reported
to have CII-specific IgG. CII-induced polychondritis displays a
strong CII-specific immune response. SP also demonstrated a
strong female preponderance, as some workers have reported
in RP but has not observed in CII-induced polychondritis. These
characteristics of SP allow for the examination of the
immunopathogenesis of polychondritis in the absence of an
overwhelming CII-specific immune response and the strong
adjuvant-induced immunostimulatory influence in CII-induced
polychondritis.
This spontaneous model of polychondritis provides a new and
unique tool to investigate both the initiatory events as well as the
immunopathogenic mechanisms occurring at cartilaginous sites
during the cyclic inflammatory assaults of polychondritis.
Introduction
Relapsing polychondritis (RP) is a human autoimmune disease
of unknown etiology. RP is relatively rare, affecting 3.5–4/
1,000,000 people, with a slight female preponderance [1].
Typical onset occurs during mid-life years with a median age
of diagnosis at 46.6 years, although cases have been reported
in newborns and in individuals over the age of 80 [2]. The most
prominent manifestations of RP are auricular chondritis, pol-
yarthritis and saddle nose deformation, with auricular chondri-
tis being the most common presenting symptom [1,2]. Any
other cartilaginous tissue may also be affected in RP, including
the eyes, the trachea and the respiratory tract [2,3]. Other tis-
sues can also be affected since some RP patients have dem-
onstrated renal involvement and skin lesions [2,4].
Autoantibodies specific for type II, type IX and type XI collagen
and for matrilin-1 [5-8] have all been detected in sera from RP
patients, supporting RP as an autoimmune disease.
We have previously described a murine model of induced
polychondritis that mimics many characteristics of RP [9,10].
BSA = bovine serum albumin; CII = type II collagen; ELISA = enzyme-linked immunosorbent assay; G6PI = glucose-6-phosphate-isomerase; PBS = 
phosphate-buffered saline; RP = relapsing polychondritis; SP = spontaneous polychondritis; tg = transgenic; TGF-β = transforming growth factor 
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Young mice (6–8 weeks of age) expressing the HLA-DQ6α8β
molecule, either the DQ6α8β transgenic (tg) or DQ6αβ8αβ tg
strains, develop polychondritis following immunization with an
emulsion of type II collagen (CII) and Complete Fruend's Adju-
vant. Induced polychondritis is characterized by a single acute
inflammatory event, by auricular chondritis or by polyarthritis,
followed by the destruction of the cartilage in both the periph-
eral joints and ears, and by pannus formation. Neither of the
parental strains, DQ6αβ tg mice or DQ8αβ tg mice, develop
polychondritis, although DQ8αβ tg mice do develop collagen-
induced arthritis [9,10]. Hansson and colleagues [11] have
also recently described a model of polychondritis, induced in
DBA mice and in Lew congenic rats by immunization with
bovine matrilin-1 in Complete Fruend's Adjuvant. In that model,
there is inflammation of the trachea and respiratory tract, fol-
lowed by their destruction; however, the ears, joints and other
cartilaginous sites are not affected.
We present evidence that when mice expressing the DQ6α8β
transgene and lacking both endogenous H2-A and H-2E
expression, either DQ6αβ8αβ tg mice or DQ6α8β tg mice,
reach middle age (between 4 and 6 months of age), they
develop spontaneous polychondritis (SP), with inflammatory
events occurring at the ears, the peripheral joints and the
nose. Auricular chondritis in SP displayed a relapsing/remit-
ting phenotype, more closely mirroring human RP than
induced polychondritis. This model occurs in the absence of
overt stimulation by an exogenous antigen such as CII, or adju-
vant, or by artificially induced trauma to any of the sites of
inflammation, and provides an excellent model that mirrors the
human disease more closely than any previously described
model of RP.
Materials and methods
Mice
The generation of mice expressing both HLA-DQ6αβ
(DQA1*0103/DQB*0601) and HLA-DQ8αβ (DQA*0301/
DQB*0302) transgenes in the absence of endogenous MHC
class II expression (Aβ0) was previously described [9], and the
mice were initially provided by Dr Chella David (Mayo Clinic,
Rochester, MN, USA). Briefly, the transgenes were introduced
into the H2f background crossed with Aβ0 mice, resulting in tg
mice expressing the DQ transgene and lacking both H2-A and
H2-E expression. All breeding occurred in laminar flow isola-
tion hoods to maintain a relatively pathogen-free environment.
Retired breeders and mice aged greater than 6 months were
moved to clean conventional rooms in the Center for Biomed-
ical Research. Mice were given rodent chow and water ad libi-
tum. All studies were approved by the University of North
Dakota Institutional Animal Care and Usage Committee. Mice
were bled retro-orbitally; the blood was spun for 10 minutes at
12,000 × g and the serum was decanted for analysis of IgG
specificity.
Total IgG levels
Total serum IgG levels were determined by ELISA as previ-
ously described [12]. Briefly, serum from experimental mice
was diluted fourfold, 1/1,000–1/64,0000, in coating buffer (1
M Na2CO3 + 1 M NaHCO3 + 1 M NaN3), and 200 μl was
added to Nunc Maxisorb microtiter plates in duplicate and
incubated at room temperature for 2 hours. Plates were
washed three times with PBS/Tween as in CII antibody, and
then 100 μl/well goat anti-mouse immunoglobulin (Sigma-
Aldrich, St Louis, MO, USA) was added and plates were incu-
bated for 2 hours at 37°C. Plates were washed three times
with PBS/Tween, and then 200 μl/well pNpp substrate
(Sigma-Aldrich) was added and incubated for 1 hour at 37°C
to visualize the reaction. The colorimetric change of each well
was determined at an optical density of 405 nm on a Ther-
momax Microplate Reader (Molecular Devices, Sunnyvale,
CA, USA), and the data were analyzed using the SOFTmax
analytical software program (Molecular Devices) and Micro-
soft Excel.
Type II collagen-specific antibody levels
One hundred microliters of collagen solution (Arthrogen-CIA®
mouse type II collagen, 5 mg/ml) diluted in 1 × collagen dilu-
tion buffer as per the manufacturer's instructions (Chondrex,
Redmond, WA, USA) was added to Nunc Maxisorb microtiter
plates (NNI, Rochester, NY, USA) and incubated overnight at
4°C. Plates were washed three times with PBS/0.5% Tween
20, were blocked by adding 1% BSA in PBS (blocking buffer)
for 2 hours at room temperature and were then washed again
three times with PBS/Tween. Experimental serum was diluted
fourfold, 1/1,000–1/64,000, in blocking buffer/Tween, and
then 200 μl was added to the plates in duplicate.
Titration of a high-titer CII-specific IgG-positive control and a
CII-negative serum control were run with each plate. Sera
were incubated for 2 hours at 37°C and were washed three
times with PBS/Tween. CII-specific mouse IgG was detected
with peroxidase-conjugated goat anti-mouse IgG (Sigma-
Aldrich) for 1 hour at 37°C. The plates were again washed
three times with PBS/Tween and the reaction visualized with
pNpp substrate (Sigma-Aldrich). The colorimetric change of
each well was determined at an optical density of 405 nm on
a Thermomax Microplate reader, and the data were analyzed
using the SOFTmax analytical software program (Molecular
Devices) and Microsoft Excel.
Detection of matrilin-1 antibodies
The presence of matrilin-1-specific IgG was determined in
sera from representative SP mice, in sera from young and mid-
dle-aged naïve DQ6αβ8αβ tg mice and in sera from CII-immu-
nized young DQ6αβ8αβ tg mice by western blot as previously
described [8]. Briefly, matrilin proteins were extracted from
bovine epiphyseal cartilages, were resolved by SDS-PAGE
and were transblotted to polyvinylidene difluoride membrane
(BioRad, Richmond, CA, USA) for western blot analysis. TheAvailable online http://arthritis-research.com/content/8/4/R134
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western blot analysis was performed with mouse serum
diluted 1:100 and probed with an alkaline phosphatase-conju-
gated goat anti-mouse IgG Fc (Jackson ImmunoResearch,
Avondale, PA, USA). The blots were developed using 5-
Bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium.
Histological analysis
Outer ears displaying clinical chondritis or outer ears from
undiseased normal controls were surgically removed from
mice anesthetized with Isofluorane (Phoenix Pharmaceutical
Inc., St Joseph, MO, USA) at various time points in the course
of disease. Ears were embedded in paraffin, were sectioned,
were mounted onto slides and were stained with hematoxylin
and eosin. Front and hind limbs were removed and dissected
from euthanized mice at the conclusion of the experiment.
Joints were decalcified and embedded in paraffin. Sections
were cut, mounted and stained with hematoxylin and eosin.
Sections of both ears and joints were also stained with
Safranin O or Toludine Blue to determine the presence of mast
cells. All sections were assessed in a blinded fashion by Dr
Maryann Sens (Department of Pathology, UNDSMHS, Grand
Forks, ND, USA) for histopathological changes and for cellular
infiltration.
Statistical analysis
Statistical analysis was carried out using the Mann–Whitney
rank sum test for nonparametric tests. P < 0.05 was consid-
ered statistically significant unless otherwise noted.
Results
Spontaneous onset of polychondritis
The incidence of SP in both DQ6αβ8αβ tg and DQ6α8β tg
strains of mice is summarized in Table 1. DQ6αβ8αβ tg mice
developed spontaneous polyarthritis at an incidence of about
80%, with 31% developing auricular chondritis. DQ6α8β tg
mice developed spontaneous polyarthritis at an incidence of
76%, with 32% developing auricular chondritis (Figure 1).
There was a strong female predisposition to developing SP in
both DQ6α8β tg expressing strains: 3.8:1 and 4.4:1
female:male ratios in the DQ6αβ8αβ tg and DQ6α8β tg
strains, respectively. Neither of the parental strains, DQ6αβ tg
mice or DQ8αβ tg mice, developed SP. As we have reported
elsewhere [13], however, DQ8αβ tg mice developed sponta-
neous polyarthritis at an incidence of 80% with, a few mice
(<1%) displaying inflammatory events at other sites.
The onset of spontaneous polyarthritis was observed from 4 to
11 months of age with a mean ± standard error of the mean
onset of 5.8 ± 0.1 months in the DQ6αβ8αβ tg strain and of
5.6 ± 0.2 months in the DQ6α8β tg strain. Female mice devel-
oped disease at a significantly earlier time points in both
strains, compared with males (Figure 1). Spontaneous auricu-
lar chondritis was delayed slightly more than 1 month from the
onset of polyarthritis in both strains (7.2 ± 0.4 and 7.4 ± 0.2
for DQ6αβ8αβ tg and DQ6α8β tg strains, respectively), and
independent of gender. The disease was clinically not as
severe as with the induced polychondritis model. These mice,
however, displayed a relapsing/remitting pattern of inflamma-
tion of their ears in which the ears would become swollen and
red (Figure 2) for a period of 1–2 weeks, after which the
inflammation would abate for a period of 1–2 weeks. This pat-
tern of cyclic inflammation more closely resembles the mani-
festation of auricular chondritis found in human RP patients.
After a period of alternating relapsing and remitting phases,
the ear eventually becomes a chronic 'cauliflower' ear and is
reduced to a small fibrous mass as shown in Figure 2. Histo-
logical analyses of ears at various time points during these
inflammatory cycles demonstrated a corresponding pattern of
infiltration and a retreat of mononuclear cells during acute and
remitting phases (data not shown).
The digits, the paws and the distal joints were affected in both
DQ6αβ8αβ tg mice and DQ6α8β tg mice displaying an
arthritic state with redness and swelling, compared with young
or middle-aged nonarthritic DQ6α8β tg expressing mice (Fig-
ure 3). The severity of polyarthritis was equivalent in both
strains with SP, and was comparable with the polyarthritis
observed in induced polychondritis (data not shown). Histo-
logical examination of sections of arthritic joints of the middle-
aged spontaneous mice demonstrated a correlation between
cellular infiltration, predominantly mononuclear cells including
mast cells (Figure 4), and the severity of polyarthritis. Sections
from joints from young, nondiseased mice and from middle-
aged, nonarthritic mice demonstrated normal joint architecture
with no signs of inflammation or infiltration of cells. Interest-
ingly, the level of inflammation and the numbers of cellular
infiltrates appeared to be lower in spontaneous mice than that
observed in collagen-immunized mice (Figure 4).
A small percentage (<25%) of the DQ6α8β tg expressing
mice with SP also displayed inflamed noses (Figure 5). Histo-
logical analysis has shown that there is a massive infiltration of
mononuclear cells (data not shown). Eyes of mice with SP
were compared with age-matched unaffected animals and
were examined for ocular involvement, including conjunctivitis,
keratitis, episcleritis or uvetis associated with RP. No changes
were observed that correlated with disease, although some
changes related to general aging were noted (data not
shown). The kidneys were also examined histologically and no
cellular infiltrate was observed (data not shown).
Previous studies in human rheumatoid arthritis and RP
patients and the collagen-induced arthritis models have shown
antibody responses to a variety of collagens, particularly CII
[5,7], as well as cartilage matrix proteins such as matrilin-1 [8],
especially during the acute phase of the disease. As CII-
induced murine models of both RP and rheumatoid arthritis are
dependent on both exogenous CII and adjuvant, it was of par-
ticular interest whether antibody levels were elevated in SPArthritis Research & Therapy    Vol 8 No 4    Lamoureux et al.
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and what antibody specificities were present in the lack of the
strong but artificial CII-specific response.
ELISAs were performed to determine total and anti-CII-spe-
cific IgG antibody levels during the disease course. All mice
displaying SP also displayed a significant increase in total IgG
levels, similar to the total IgG response observed in induced
polychondritis in young CII-immunized mice (Figure 6). None
of the spontaneous mice, however, displayed any detectable
CII-specific antibodies (Figure 6). To determine whether mice
developing SP displayed an antimatrilin-1 antibody response,
as detected in RP patients [8], matrilin proteins were sepa-
rated by SDS-PAGE, were transferred to a polyvinylidene dif-
luoride membrane and were blotted with DQ6αβ8αβ tg
experimental sera.
Figure 7 shows a representative blot in which sera from mice
were blotted against either matrilin proteins or CII. A strong
IgG response to matrilin-1 was detected in sera from mice
developing SP, but these mice lacked any CII-specific IgG.
Conversely, young, CII-immunized DQ6αβ8αβ tg sera dis-
played antibodies to CII but lacked significant antibodies to
matrilin-1. Sera from middle-aged DQ6αβ8αβ tg mice not
exhibiting any clinical signs of polychondritis did have low lev-
els of matrilin-1-specific IgG, yet significantly lower than those
with SP. These data suggest that CII is probably not involved
in the autoimmune reaction responsible for SP, and suggest
that matrilin-1 may be at least one of the putative autoantigens
involved in either the induction or progression of SP disease.
Discussion
Few spontaneous models of arthritic disease have been
observed [14-16], and none have as yet described all the man-
ifestations necessary to be considered a spontaneous model
of relapsing polychondritis – which is characterized not only by
polyarthritis, but also by involvement of the ears, the nose and
possibly the trachea. Hansson and colleagues have described
a chondritic model in which matrilin-1 immunization induces
involvement of the respiratory tract but in which peripheral
joints and ears are unaffected [11].
Table 1
Summary of spontaneous polychondritis in DQ6α8β transgenic mouse strains
Mouse strain Incidence of spontaneous auricular chondritis (%) Incidence of spontaneous arthritis (%)
DQ6αβ8αβ (n = 125) 31.2 80.8
DQ6α8β (n = 114) 31.6 75.4
Mice, allowed to age with no artificial immunostimulation either in the barrier breeding facility or in the conventional animal care rooms, were 
examined three times per week for the onset of polychondritis from 3 months to 1 year of age. Representative mice were euthanized and tissues 
were examined histologically to confirm the presence of disease. There was no difference in the disease incidence, the day of onset or the severity 
of disease, determined by the location of the mice.
Figure 1
Incidence and onset of spontaneous polychondritis in female versus male DQ6α8β transgenic expressing mice Incidence and onset of spontaneous polychondritis in female versus male DQ6α8β transgenic expressing mice. The onset of auricular chondritis 
and polyarthritis was determined by visual inspection and was confirmed by histological analyses as described in Table 1. Females (black shading) 
were more highly susceptible to both auricular chondritis and polyarthritis, and displayed clinical disease earlier than males (grey shading).Available online http://arthritis-research.com/content/8/4/R134
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We describe herein a model of spontaneous autoimmune
polychondritis that occurs in mice expressing the DQ6α8β
transgene without the exogenous stimulation by antigen or
adjuvant and the possible interference those substances may
add. The mean onset of disease occurs about 6 months of
age. Although difficult to directly correlate mouse years with
human years, this places the onset of disease approximately at
middle age, or near the fourth or fifth decade of life in human
years, matching the mean onset of RP in humans. There is a
strong female preponderance, which correlates with some
reports of human relapsing polychondritis [1] and autoimmune
diseases in general. This would suggest that the gender-
related factors that make females more prone to autoimmune
responses may also be occurring in this newly identified
model, and thus may be better understood. It is of note that
enhanced female susceptibility is not observed in the CII-
induced model of polychondritis or arthritis.
Human studies have shown that as many as two-thirds of RP
patients do not develop antibodies to CII during the course of
disease [17], correlating to the finding that there was not a CII-
specific immune response during SP. There are, however, sig-
nificant total IgG responses in both SP and RP, suggesting a
Figure 2
Representative photographs of relapsing/remitting auricular chondritis  in DQ6α8β transgenic expressing mice Representative photographs of relapsing/remitting auricular chondritis 
in DQ6α8β transgenic expressing mice. Ears were photographed at 
each of the clinical stages of auricular chondritis occurring in spontane-
ous polychondritis: (a) a normal, nonchondritic ear; (b) an acute chon-
dritic ear in an inflamed cycle; (c) an acute chondritic ear in an 
noninflamed cycle; and (d) a chronically chondritic ear in which the car-
tilage has been destroyed.
Figure 3
Representative photographs of polyarthritis in DQ6α8β transgenic  expressing mice Representative photographs of polyarthritis in DQ6α8β transgenic 
expressing mice. (a) A normal rear mouse paw and (b) an acute 
arthritic rear mouse paw, representative of polyarthritis occurring during 
spontaneous polychondritis.
Figure 4
Histological assessment of arthritic synovium sections from spontane- ous polychondritis and type II collagen-induced polychondritis Histological assessment of arthritic synovium sections from spontane-
ous polychondritis and type II collagen-induced polychondritis. Sec-
tions obtained from several arthritic rear paws were stained either with 
(a), (b) hematoxylin and eosin to determine the general cellular infiltra-
tion or with (c), (d) Toludine Blue to determine the mast cell infiltration. 
The cellular infiltration during (a), (c) spontaneous polychondritis is 
compared with (b), (d) type II collagen-induced polychondritis. All sec-
tions are displayed at 10 ×.
Figure 5
Nasal chondritis during spontaneous polychondritis in DQ6α8β trans- genic expressing mice Nasal chondritis during spontaneous polychondritis in DQ6α8β trans-
genic expressing mice. Representative (a) uninflamed and (b), (c) 
inflamed noses from mice with spontaneous polychondritis. Redness, 
swelling and accompanying hair-loss was observed in approximately 
23% of the DQ6α8β transgenic expressing mice observed.Arthritis Research & Therapy    Vol 8 No 4    Lamoureux et al.
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role for antibodies in the pathogenesis of disease. In addition,
there is an increased infiltration of mast cells into the synovium
and ears during SP, which also correlates with other recent
reports suggesting a pathogenic role for the elevated IgG
through mast cells in RA and animal models of arthritis [18-
21]. We are currently investigating the contribution the mast
cells infiltrating into the cartilaginous tissues have toward the
pathogenesis of SP. In addition, a strong antibody response to
matrilin-1 is observed during SP, raising the possibility that
matrilin-1 may be the putative autoantigen in the initiation of
SP. This would correspond with an antimatrilin-1 antibody
response observed in human RP patients [8] and with the abil-
ity of heterologous matrilin-1 to induce a polychondritis-like
disease in mice [11].
There has been significant interest in another putative autoan-
tigen, the ubiquitous protein glucose-6-phosphate-isomerase
(G6PI), because antibodies specific for G6PI have been found
Figure 6
Total and type II collagen-specific IgG levels in DQ6α8β transgenic expressing mice Total and type II collagen-specific IgG levels in DQ6α8β transgenic expressing mice. Sera samples from (a) 10 middle-aged mice with spontaneous 
polychondritis, (b) from 10 young mice with type II collagen (CII)-induced polychondritis, (c) from 10 young naïve mice not displaying clinical disease 
or (d) from 10 middle-aged mice not displaying clinical disease were collected and assessed for the levels of total IgG and CII-specific IgG by 
ELISA. Polychondritic mice had greatly elevated levels of total IgG, but only CII-induced polychondritic mice had elevated CII-specific IgG. OD, opti-
cal density.
Figure 7
Matrilin-1-specific IgG present during spontaneous polychondritis in DQ6α8β transgenic mice Matrilin-1-specific IgG present during spontaneous polychondritis in DQ6α8β transgenic mice. Representative sera from middle-aged mice display-
ing spontaneous polychondritis, from young naïve mice, from young mice with type II collagen (CII)-induced polychondritis or from middle-aged mice 
not displaying clinical disease were separated by SDS-PAGE electrophoresis and were blotted for the presence of matrilin-1-specific or CII-specific 
IgG. Although minor levels of matrilin-1-specific IgG were detectable in each sera that increased with age, it was highly elevated in each spontane-
ous polychondritis mouse examined. CII-specific IgG was only detected in the CII-immunized mouse, as also observed by ELISA.Available online http://arthritis-research.com/content/8/4/R134
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deposited in the joints of RA patients as well as in mouse mod-
els of RA [22]. There have not, however, been any reports of
auricular chondritis in K/B × N mice or of anti-G6PI antibodies
in RP patients. Both DQ6α8β tg expressing strains displayed
high titers of anti-G6PI IgG1 regardless of the presence of clin-
ical disease (Bradley and Wooley, personal communication),
suggesting that while the deposition of antibody complexes
into the joint may contribute to the overall destruction of syno-
vial or auricular tissue, it is most probably not the initial trigger
in pathogenesis of autoimmune damage in SP.
Treatment with transforming growth factor beta (TGF-β) has
been shown recently to provide some protective effect against
collagen-induced arthritis in young, susceptible mice, although
the effects are not long-lasting. In aging mice, however, treat-
ment with TGF-β has been shown to block induction of arthritis
altogether [23]. DQ6α8β tg expressing mice displayed an
overall increase in the levels of TGF-β, regardless of the pres-
ence of disease, as compared with controls (naïve B10.T(6R)
mice), with many samples reading high and out of range (Bra-
dley and Cafruny, personal communication). It is unclear how
this finding correlates with the immunoregulatory role of TGF-
β in arthritis. It is possible, however, that the elevated TGF-β
levels represent an active attempt by these mouse strains to
downregulate the vigorous (auto)immune response. Alterna-
tively, the TGF-β serum levels may represent another form of
dysregulation, such as the role of TGF-β-specific antibodies in
lupus-like diseases [24].
Correlations have been made between the HLA genotype and
the genetic predisposition to many autoimmune diseases,
including rheumatoid arthritis (HLA-DR4, DQ8), insulin-
dependent diabetes mellitus (DR4, DQ8), thyroiditis (DR3)
and multiple sclerosis (DR4) [25]. The occurrence of SP in a
mouse expressing the DQ6α8β transgene and lacking endog-
enous MHC class II expression may provide insight into the
potential contribution of mixed haplotype molecules to RP, and
perhaps more generally to immune responses. It is of note that
HLA-DR4 subtypes, some of which are linked with DQ8 due
to linkage disequilibrium, have been associated with RP
[2,26]. This association is true of the DR4 subtypes linked with
DQ8 and the subtypes not linked with DQ8, however,
suggesting that the RP HLA-D association may be more com-
plex than the allelic association. This may also suggest that
one or more mixed haplotypes molecules (e.g. DQ6α8β) may
be able to present the pathogenic epitopes responsible for
polychondritis.
Conclusion
The SP model of RP described herein is a model lacking arti-
ficial stimulation or enhancement in which the immunopatho-
genic events underlying inflammation of the joints, the ears, the
nose and perhaps other cartilaginous sites can be examined,
including, but not limited to, the role of antibody and mast cells
in RP and related diseases. In addition, this model should pro-
vide an excellent tool to evaluate therapeutic regimes for RP
and other inflammatory autoimmune diseases. As SP occurs in
strains of mice expressing the mixed haplotype DQ6α8β mol-
ecule, it may also provide insight into genetic susceptibility of
diseases in which the allelic models of predisposition have not
provided clarity.
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